Geertjan van Tienhoven

Author

Amsterdam UMC Location University of Amsterdam ORCID

Also Known As

Coen R. N. Rasch, Eva Versteijne, G VANTIENHOVEN, G van Tienhoven, G. J. van Tienhoven, G. Tienhoven, G. Van Tienhoven, G. van Tienhoven, G.-J. van Tienhoven, G.J. Van Tienhoven

394

Publications

19.3K

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location University of Amsterdam University of Amsterdam Radboud University Nijmegen The Netherlands Cancer Institute Amsterdam University Medical Centers

About

Geertjan van Tienhoven is an author at Amsterdam UMC Location University of Amsterdam specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	61	7.7K
2	Health Sciences	20	25	1.6K
3	Nursing	4	4	153
4	Engineering	2	2	53
5	Arts	1	1	67

Geertjan van Tienhoven

120

Publications

15K

Citations

H-Index

Page 1

	Year	Citations
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial Mila Donker, Geertjan van Tienhoven, Marieke E. Straver, The Lancet Oncology Surgical OncologyBreast OncologyRadiation TherapyMedicineBreast Cancer	2014	1.8K
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial Eva Versteijne, Mustafa Suker, Karin Groothuis, Journal of Clinical Oncology	2020	1K
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer Philip Poortmans, Sandra Collette, Carine Kirkove, New England Journal of Medicine	2015	1K
Duration of Androgen Suppression in the Treatment of Prostate Cancer M. Bolla, Theodorus M. de Reijke, Geertjan van Tienhoven, New England Journal of Medicine	2009	952
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study M. Bolla, Geertjan van Tienhoven, Padraig Warde, The Lancet Oncology Radiation MedicineUrologyRadiation TherapyMedicineHigh Metastatic Risk	2010	935
Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911) M. Bolla, Hendrik Van Poppel, Bertrand Tombal, The Lancet Radiation MedicineSurgical OncologyUrologyRadiation TherapyHigh-risk Prostate Cancer	2012	856
The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study Elsbeth Steenland, J.W.H. Leer, Hans C. van Houwelingen, Radiotherapy and Oncology Painful Bone MetastasesMedicineBone RemodelingOsteoarthritisGlobal Analysis	1999	678
The Effect of Low Molecular Weight Heparin on Survival in Patients With Advanced Malignancy Clara Klerk, Susanne M. Smorenburg, Hans-Martin Otten, Journal of Clinical Oncology	2005	600
Differences in Risk Factors for Local and Distant Recurrence After Breast-Conserving Therapy or Mastectomy for Stage I and II Breast Cancer: Pooled Results of Two Large European Randomized Trials Adri C. Voogd, Maja Nielsen, Johannes L. Peterse, Journal of Clinical Oncology	2001	560
Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial Sanne A. L. Bartels, Mila Donker, Coralie Poncet, Journal of Clinical Oncology	2022	322

Page 1